An analysis of the immune response to pneumococcal proteins expressed during carriage in humans may reveal potential protein vaccine candidates. Half of the subjects in an experimental model of human carriage became colonized for 27-122 days; the other subjects were naturally resistant to colonization by the type 23F pneumococcus. IgG antibodies that recognized a 22 kD band (subsequently identified as the truncated N-terminus of pneumococcal surface protein A (PspA)) appeared after inoculation with pneumococcus in colonized subjects (6 of 7), while in all uncolonized subjects (7 of 7), PspA-specific antibodies were present prior to inoculation, suggesting a correlation between presence of PspA-specific IgG and resistance to colonization. The human serum and secretory antibody response to PspA was further elucidated by ELISA. This proposal examines the potential for PspA as a vaccine candidate against pneumococcal colonization and utilizes rational vaccine design based on the susceptibility to carriage in humans to identify novel vaccine candidates as well as to evaluate previously described vaccine antigens. In addition, the conservation of PspA expression in clinical isolates of pneumococcus will be examined to determine the effectiveness of a protein vaccine based soley on PspA. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32AI051115-01A1
Application #
6584858
Study Section
Special Emphasis Panel (ZRG1-VACC (01))
Program Officer
Klein, David L
Project Start
2003-06-01
Project End
2006-05-31
Budget Start
2003-06-01
Budget End
2004-05-31
Support Year
1
Fiscal Year
2003
Total Cost
$48,148
Indirect Cost
Name
University of Pennsylvania
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104